Trevi Therapeutics Inc (TRVI)

May 24, 2026

Clear Street Maintains Trevi Therapeutics (TRVI) Buy Recommendation - MSN

May 24, 2026

May 20, 2026

Trevi Therapeutics Announces Proposed Public Offering of Common Stock - Quantisnow

May 20, 2026

May 20, 2026

TRVI Reiterated by Needham -- Price Target Maintained at $23 - GuruFocus

May 20, 2026

May 20, 2026

TRVI News | TREVI THERAPEUTICS INC (NASDAQ:TRVI) - ChartMill

May 20, 2026

May 19, 2026

Trevi Therapeutics stock (US89357P1049): short interest remains high as Wall Street targets signal u - AD HOC NEWS

May 19, 2026

May 18, 2026

Trevi Therapeutics maps Haduvio chronic cough push, sees cash runway into 2030 - MSN

May 18, 2026

May 17, 2026

Trevi Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates - GuruFocus

May 17, 2026

May 15, 2026

Trevi Therapeutics, Inc. (TRVI) Analyst/Investor DaySlideshow (NASDAQ:TRVI) 2026-05-15 - Seeking Alpha

May 15, 2026

May 14, 2026

Trevi Therapeutics, Inc.Common Stock (Nasdaq:TRVI) Stock Quote - FinancialContent

May 14, 2026

May 13, 2026

Trevi Therapeutics Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus

May 13, 2026

May 13, 2026

TradingKey - TradingKey

May 13, 2026

May 11, 2026

Revenue per share of Trevi Therapeutics, Inc. – NASDAQ:TRVI - TradingView

May 11, 2026

May 10, 2026

TRVI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

May 10, 2026

May 10, 2026

Nan Fung Trinity HK Ltd. Boosts Holdings in Trevi Therapeutics, Inc. $TRVI - MarketBeat

May 10, 2026

May 10, 2026

F m Investments LLC Buys New Position in Trevi Therapeutics, Inc. $TRVI - MarketBeat

May 10, 2026

May 10, 2026

Comerica Bank Has $1.04 Million Stake in Trevi Therapeutics, Inc. $TRVI - MarketBeat

May 10, 2026

May 09, 2026

Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030 - sharewise.com

May 09, 2026

May 09, 2026

Trevi Therapeutics (NASDAQ:TRVI) Stock Rating Lowered by Wall Street Zen - MarketBeat

May 09, 2026

May 08, 2026

Oppenheimer Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $24 - 富途牛牛

May 08, 2026

May 08, 2026

Stifel Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Raises Target Price to $30 - 富途牛牛

May 08, 2026

May 08, 2026

Equities Analysts Offer Predictions for TRVI Q2 Earnings - MarketBeat

May 08, 2026

May 08, 2026

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A Biotech With 59.82% Potential Upside - DirectorsTalk Interviews

May 08, 2026

May 08, 2026

H.C. Wainwright Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $21 - Moomoo

May 08, 2026

May 07, 2026

NEA stake in Trevi now 10.5% on share increase (TRVI) - Stock Titan

May 07, 2026

May 07, 2026

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q1 2026 Earnings Call Transcript - Insider Monkey

May 07, 2026

May 07, 2026

Research Analysts Set Expectations for TRVI FY2030 Earnings - MarketBeat

May 07, 2026

May 06, 2026

Trevi Therapeutics, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 06, 2026

May 06, 2026

Why Trevi Therapeutics (TRVI) Is Up 5.9% After Extending Its Cash Runway Into 2030 - Yahoo Finance

May 06, 2026

May 06, 2026

FMR LLC shows 6.3% stake in Trevi Therapeutics (NASDAQ: TRVI) - Stock Titan

May 06, 2026

May 06, 2026

B. Riley Adjusts Trevi Therapeutics Price Target to $21 From $16, Maintains Buy Rating - marketscreener.com

May 06, 2026

May 06, 2026

Trevi Therapeutics (NASDAQ:TRVI) Price Target Lowered to $23.00 at Needham & Company LLC - MarketBeat

May 06, 2026

May 06, 2026

HC Wainwright Reaffirms Buy Rating for Trevi Therapeutics (NASDAQ:TRVI) - MarketBeat

May 06, 2026

May 06, 2026

Trevi Therapeutics Q1 2026 Earnings Call Transcript - MarketBeat

May 06, 2026

May 06, 2026

MSN Money - MSN

May 06, 2026

May 06, 2026

Stifel reiterates Buy rating on Trevi Therapeutics stock at $18 - Investing.com

May 06, 2026

May 06, 2026

Stifel reiterates Buy rating on Trevi Therapeutics stock at $18 By Investing.com - Investing.com Canada

May 06, 2026

May 06, 2026

Trevi Therapeutics Q1 Earnings Call Highlights - MarketBeat

May 06, 2026

May 05, 2026

Trevi Therapeutics : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com

May 05, 2026

May 05, 2026

Earnings call transcript: Trevi Therapeutics Q1 2026 highlights cash boost and clinical progress - Investing.com UK

May 05, 2026

May 05, 2026

TRVI: Cash runway into 2030 supports multiple advancing chronic cough trials and new patent coverage - TradingView

May 05, 2026

May 05, 2026

Earnings call transcript: Trevi Therapeutics Q1 2026 highlights cash boost and clinical progress By Investing.com - Investing.com South Africa

May 05, 2026

May 05, 2026

Trevi Therapeutics Q1 net loss widens as R&D costs rise - TradingView

May 05, 2026

May 05, 2026

Trevi Therapeutics (NASDAQ:TRVI) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat

May 05, 2026

May 05, 2026

Q1 2026 Trevi Therapeutics Inc Earnings Call Transcript - GuruFocus

May 05, 2026

May 05, 2026

Trevi Therapeutics (NASDAQ: TRVI) raises $162M, funds cough trials - Stock Titan

May 05, 2026

May 05, 2026

Trevi Therapeutics (NASDAQ: TRVI) widens Q1 loss and raises $173M - Stock Titan

May 05, 2026

May 05, 2026

Fresh $162M gives Trevi runway into 2030 ahead of Phase 3 cough trials - Stock Titan

May 05, 2026

May 05, 2026

Trevi Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 05, 2026

May 05, 2026

BRIEF-Trevi Therapeutics Q1 Net Income USD -13.192 Million - TradingView

May 05, 2026